Astrana’s Full-Risk Pivot: Record Profits, Raised Guide, and a Medicaid Rebalancing Bet
Q2 2026: Revenue +49%, EBITDA +43%, net leverage down to 2.26x as the company accelerates value-based risk and Prospect integration.
ASTH · Earnings Call · 2026-08-06
A Record Quarter, a Sharper Pivot
Astrana Health delivered a standout second quarter. Revenue rose 49% year-over-year to $973 million, adjusted EBITDA climbed 43% to $69 million, and adjusted EPS hit a record $0.80. Free cash flow for the first half totaled $93 million. "These results continue to demonstrate the scalability of our AI-native healthcare operating system and the consistency of its execution," CEO Brandon Sim said. Management raised full-year EBITDA guidance to $255–$280 million while reinvesting a "substantial portion" of outperformance into growth. More striking than the headline numbers is the strategic change underneath. The company is pushing harder into risk arrangements — now 81% of capitation revenue and 42% of membership sits in full-risk contracts. In California, they're rebalancing Medi-Cal members from professional to full risk, a move expected to shift "tens of thousands" of lives over the next 12 months. This is a deliberate realignment of the Care model toward full accountability.The Full-Risk Machine: From Professional to Full Risk
Brandon Sim was explicit about the logic: "We would want to be fully accountable for the results that our model is driving, across all lines of business, but certainly especially in the Medi-Cal business." That's a departure from the prior posture of gradually testing partial risk. Now, the platform's improved predictability is letting Astrana accelerate. New Medicare Advantage deals were signed in Hawaii and Texas, and the Texas full-risk partnership with a large national payer is two quarters in and performing as expected. This isn't just an extension of the old playbook. In the prior quarter's call, Sim had framed full risk as a slower, step-wise progression: "we are seeing success in moving contracts to a delegated model even outside of California." Today, the company is moving faster than that, converting entire blocks of Medicaid members to full risk while simultaneously adding new geographies. The economic bet is that a better operating system — with real-time data, AI-driven care management, and longitudinal patient views — reduces the uncertainty of capitation enough to make these transitions accretive.AI at the Orchestration Layer
The AI narrative is now central to the margin story. G&A as a percentage of revenue improved roughly 210 basis points year-over-year, and the company expects to exit the year at ~6%. AI agents are handling claims, referrals, and member outreach; over 500,000 automated member encounters occur monthly, and handling times in claims/referrals are down more than 50%. Sim framed this as transformative: "We truly have the ability to fulfill the potential of getting people more care," not just cutting costs. That efficiency is showing up in the numbers. "G&A as a percentage of revenue improved approximately 210 basis points year-over-year in the second quarter," Chan Basho reiterated. The AI agents are also beginning to nudge medical loss ratios — inpatient admits per thousand in Medicare were flat year-over-year, a sign that AI-enabled navigation is bending the utilization curve.The result is intelligent automation that spans the organization, becomes more capable over time, and creates more value as the platform scales.